RITALIN

This brand name is authorized in Austria, Australia, Canada, Germany, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, Netherlands, New Zealand, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RITALIN contains one active pharmaceutical ingredient (API):

1 Methylphenidate UNII 4B3SC438HI - METHYLPHENIDATE HYDROCHLORIDE

Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. Read about Methylphenidate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RITALIN Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA04	Methylphenidate	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12116Q, 2276T, 2280B, 2283E, 3440C, 8839F
Country: CA	Health Products and Food Branch	Identifier(s): 00005606, 00632775
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06970716, 06970745, 06970751, 06970774, 06970780, 06970805, 06970811, 06970863, 06970886, 06971495, 06973620, 06974306, 08822167, 09621117, 09621123, 10002566, 10533097, 10533128, 11100443, 11691160, 11691177
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 201644, 23717, 374158, 379313, 379316, 379318, 379320, 379333, 85726
Country: HK	Department of Health Drug Office	Identifier(s): 00212, 52178, 62194, 65119
Country: IE	Health Products Regulatory Authority	Identifier(s): 44237, 44327, 44340, 44345
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4753, 4754, 4755, 587, 6845
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179009F1035
Country: MT	Medicines Authority	Identifier(s): AA288/02701
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 44836, 586M2002
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2194
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10181, 10182, 10183, 13727, 16348, 986
Country: SG	Health Sciences Authority	Identifier(s): 03542P, 11335P, 12351P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283191
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504011104
Country: US	FDA, National Drug Code	Identifier(s): 0078-0370, 0078-0371, 0078-0372, 0078-0424, 0078-0439, 0078-0440, 0078-0441
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/1.2/0186, 36/1.2/0187, 36/1.2/0188, 44/1.2/0594, B/1.2/1610